A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at...A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at...
Treatment with a calcineurin inhibitor within 2 months prior to screening or during screening ...
https://classic.clinicaltrials.gov/ct2/show/NCT05797610?titles=IMAgINATION&draw=2&rank=7